FiercePharma2d
EMA backs Merck’s Welireg, Bayer’s ATTR med and Gilead’s liver drug from $4.3B deal
Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...
Medscape2d
Europe Approves Its First Drug for Von Hippel-Lindau Tumors
Defective VHL protein is also present in most cases of advanced clear cell renal cell carcinoma (RCC), so a recommendation ...
Merck gets positive EU regulatory opinion for Welireg
The committee also recommended conditional approval of the drug for the treatment of adult patients with advanced clear cell ...
Renal & Urology News8d
Advances in the Treatment of Bladder, Kidney Cancer
LUGPA annual meeting, Gautam Jayram, MD, reviewed important developments therapeutics and diagnosis and staging.
Renal & Urology News12d
CAR T-Cell Therapy ALLO-316 Produces Responses in Rel/Ref ccRCC
Phase 1 results support further evaluation of ALLO-316 in patients with CD70-positive clear cell renal cell carcinoma, according to researchers.
Medscape25d
ImmunoPET May Change Standard of Care in Kidney Cancer Diagnosis
Clear cell renal cell carcinoma (RCC) comprises 80% of all primary kidney malignancies and causes 90% of kidney cancer deaths. But it is notoriously tough to diagnose. RCC is not easily ...